Canton Strategic Holdings, Inc. (CNTN)
NASDAQ: CNTN · Real-Time Price · USD
1.950
+0.220 (12.72%)
Oct 21, 2026, 2:10 PM EDT - Market open
Canton Strategic Holdings Market Cap
Canton Strategic Holdings has a market cap or net worth of $155.38 million as of October 21, 2026. It is the 23,112th most valuable company in the world and the 3,858th biggest in the United States. Its market cap has increased by 546.22% in one year.
Market Cap
155.38M
Enterprise Value
118.14M
1-Year Change
546.22%
Global Rank
Country Rank
#3,858 United States
Category
ChartMarket Cap Chart
Since January 12, 2022, Canton Strategic Holdings's market cap has increased from $32.56M to $155.38M, an increase of 377.17%. That is a compound annual growth rate of 38.71%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 21, 2026 | 155.38M | 40.71% |
| Dec 31, 2025 | 110.43M | 2,713.07% |
| Dec 31, 2024 | 3.93M | 205.38% |
| Dec 29, 2023 | 1.29M | -71.40% |
| Dec 30, 2022 | 4.49M | -86.20% |
| Jan 12, 2022 | 32.56M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Molecular Partners AG | 141.95M |
| Veraxa Biotech AG | 141.41M |
| Satellos Bioscience | 138.25M |
| Protara Therapeutics | 137.69M |
| Retension Pharmaceuticals | 136.06M |
| Innate Pharma | 133.08M |
| Korro Bio | 131.21M |
| Atrium Therapeutics | 130.17M |